HomeQuestion

For pediatric severe aplastic anemia, is an alemtuzumab (campath) based conditioning regimen preferred over ATG?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?

How would you manage aplastic anemia refractory to multiple agents?

How long do you continue to follow children with now resolved autoimmune hemolytic anemia in hematology clinic to monitor for recurrence or secondary conditions?

For transplant-ineligible aplastic anemia planned for immunosuppression, how do you approach duration and tapering of cyclosporine and eltrombopag?

What is your approach to managing iron overload in children with transfusion-dependent beta thalassemia who have adherence challenges or toxicity with standard chelation regimens?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.